The Metabolic Syndrome in Cancer Survivors

Overview

Journal Lancet Oncol

Specialty Oncology

Date 2010 Feb 16

PMID 20152771

Citations 83

Authors

Esther C de Haas

Sjoukje F Oosting

Joop D Lefrandt

Bruce Hr Wolffenbuttel

Dirk Th Sleijfer

Jourik A Gietema

Affiliations

Soon will be listed here.

Abstract

The metabolic syndrome, as a cluster of cardiovascular risk factors, may represent an important connection between cancer treatment and its common late effect of cardiovascular disease. Insight into the aetiology of the metabolic syndrome after cancer treatment might help to identify and treat cancer survivors with increased cardiovascular risk. In this review, we summarise current knowledge on the prevalence and pathophysiology of the metabolic syndrome in cancer survivors, and discuss current intervention strategies with an emphasis on new developments.

Citing Articles

Novel metabolic prognostic score for predicting survival in patients with cancer.

Shi J, Liu C, Zheng X, Chen Y, Zhang H, Liu T Sci Rep. 2025; 15(1):1322.

PMID: 39779840 PMC: 11711642. DOI: 10.1038/s41598-025-85287-6.

Implementation of Regular Lifestyle Counseling During Long-Term Follow-Up Care of Childhood Cancer Survivors: Monocentric Prospective Study.

Richter F, Kronziel L, Konig I, Langer T, Gebauer J JMIR Cancer. 2024; 10:e59614.

PMID: 39723991 PMC: 11694152. DOI: 10.2196/59614.

Cardiovascular diseases in patients with cancer: A comprehensive review of epidemiological trends, cardiac complications, and prognostic implications.

Alshahrani A, Kontopantelis E, Morgan C, Ravindrarajah R, Martin G, Mamas M Chin Med J (Engl). 2024; 138(2):143-154.

PMID: 39719690 PMC: 11745857. DOI: 10.1097/CM9.0000000000003419.

The association between metabolic syndrome and lung cancer risk: a Mendelian randomization study.

Wei Z, Hu Y, Zuo F, Wen X, Wu D, Sun X Sci Rep. 2024; 14(1):28494.

PMID: 39558018 PMC: 11574301. DOI: 10.1038/s41598-024-79260-y.

Chemotherapy and Metabolic Syndrome: A Comprehensive Review of Molecular Pathways and Clinical Outcomes.

Trehan S, Singh G, Singh A, Bector G, Jain A, Antil P Cureus. 2024; 16(8):e66354.

PMID: 39246917 PMC: 11379418. DOI: 10.7759/cureus.66354.